Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.
Type:
Grant
Filed:
June 30, 2021
Date of Patent:
November 14, 2023
Assignee:
ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
Inventors:
Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
Abstract: Provided herein is technology relating to methods for assaying a cell-containing body sample and particularly, but not exclusively, to treating a sample under conditions to cause cell lysis, preferably by means of a detergent; and subjecting the lysed sample to conditions causing the cleavage of nucleic acid molecules. The technology additionally relates to using nucleic acid cleavage conditions to enhance a membrane assay, a device for carrying out such an assay, and a kit for use in the assay.
Type:
Grant
Filed:
January 10, 2018
Date of Patent:
August 30, 2022
Assignee:
ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
Inventors:
Jostein Holtlund, Andrew Campbell, Stig Morten Borch